Haplotype analyses of the c.1027C>T and c.2167_2168delAT recurrent truncating mutations in the breast cancer-predisposing gene PALB2
暂无分享,去创建一个
T. Walsh | M. King | O. Olopade | P. Radice | P. Peterlongo | S. Manoukian | S. Neuhausen | S. Casadei | Jessica B. Mandell | A. Falanga | J. Weitzel | S. Volorio | Y. Ding | C. Tondini | Irene Catucci | C. Ricker | M. Marchetti | Filomena Ficarazzi | M. Franchi | A. Adamson
[1] T. Dörk,et al. Prevalence of PALB2 mutation c.509_510delGA in unselected breast cancer patients from Central and Eastern Europe , 2014, Familial Cancer.
[2] B. Bonanni,et al. PALB2 sequencing in Italian familial breast cancer cases reveals a high-risk mutation recurrent in the province of Bergamo , 2014, Genetics in Medicine.
[3] P. Radice,et al. Characterization of an Italian Founder Mutation in the RING-Finger Domain of BRCA1 , 2014, PloS one.
[4] Benjamin J. Raphael,et al. Integrated Analysis of Germline and Somatic Variants in Ovarian Cancer , 2014, Nature Communications.
[5] M. Southey,et al. PALB2 and breast cancer: ready for clinical translation! , 2013, The application of clinical genetics.
[6] T. Walsh,et al. Contribution of inherited mutations in the BRCA2-interacting protein PALB2 to familial breast cancer. , 2011, Cancer research.
[7] Daniel J. Park,et al. A PALB2 mutation associated with high risk of breast cancer , 2010, Breast Cancer Research.
[8] T. Walsh,et al. Detection of inherited mutations for breast and ovarian cancer using genomic capture and massively parallel sequencing , 2010, Proceedings of the National Academy of Sciences.
[9] M. Dąbrowska,et al. A novel germline PALB2 deletion in Polish breast and ovarian cancer patients , 2010, BMC Medical Genetics.
[10] J. Hopper,et al. Penetrance Analysis of the PALB2 c.1592delT Founder Mutation , 2008, Clinical Cancer Research.
[11] W. Foulkes,et al. Identification of a novel truncating PALB2 mutation and analysis of its contribution to early-onset breast cancer in French-Canadian women , 2007, Breast Cancer Research.
[12] S. Seal,et al. PALB2, which encodes a BRCA2-interacting protein, is a breast cancer susceptibility gene , 2007, Nature Genetics.
[13] F. Couch,et al. Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. , 2006, Molecular cell.
[14] Mathew W. Wright,et al. Guidelines for human gene nomenclature. , 2002, Genomics.
[15] J C Murray,et al. Pediatrics and , 1998 .
[16] S Povey,et al. Guidelines for human gene nomenclature (1997). HUGO Nomenclature Committee. , 1997, Genomics.
[17] Alberto Piazza,et al. The History and Geography of Human Genes: Abridged paperback Edition , 1996 .
[18] D. F. Roberts,et al. The History and Geography of Human Genes , 1996 .
[19] W. Foulkes,et al. Breast-cancer risk in families with mutations in PALB2. , 2014, The New England journal of medicine.